SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH H impact

Quest Diagnostics to offer FDA-cleared Roche pTau217 blood test

Quest Diagnostics says it will offer the FDA-cleared Roche pTau217 blood test to assess Alzheimer's disease pathology.

DGX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.